Celgene International Sárl (CELG) Announces U.S. FDA Grants Priority Review for ABRAXANE® sNDA in Advanced Pancreatic Cancer
More...
|
Opko Health, Inc. Surpasses 50% Enrollment in First Phase 3 Trial of Rayaldy™ (CTAP101 Capsules)
More...
|
Novo Nordisk A/S (NVO) Reports 8% Weight Loss in Phase 3a Obesity Trial With liraglutide 3 mg
More...
|
Zensun Announces Positive Clinical Results for Neucardin™ to Improve Heart Function and Reduce Mortality in Chronic Heart Failure Patients
More...
|
TauRx Therapeutics Release: First UK Patients Enroll in Phase 3 Clinical Trials of LMTX™ for Alzheimer's Disease
More...
|
Takeda Pharmaceutical Co. Ltd. (TKPYY) Initiates TOURMALINE-MM2 Pivotal Phase 3 Trial of MLN9708 in Patients With Newly Diagnosed Multiple Myeloma
More...
|
Repros Therapeutics Inc. (RPRX) Release: FDA Recommends Running Phase 2b Trial of Proellex®-V in the Treatment of Severe Menstrual Bleeding Associated With Uterine Fibroids
More...
|
Merrimack Pharmaceuticals Inc. Completes Enrollment in a Phase 2 Study of MM-121 in Combination With Exemestane in Breast Cancer
More...
|
Lpath, Inc. Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
More...
|
OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Cedar™ Clinical Trial Evaluating OGX-427 in Combination With Chemotherapy in Advanced Squamous Cell Lung Cancer
More...
|
Lightlake Therapeutics Inc. (LLTP)’ Binge Eating Disorder Treatment Phase II Trial Results Presented at American Psychiatric Association 2013 Annual Meeting
More...
|
Virobay Inc. Initiates a Phase 1 Trial of VBY-036, a Compound Intended for the Treatment of Neuropathic Pain
More...
|
Spring Bank Pharmaceuticals, Inc. Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
More...
|
First Patient Dosed in the Phase I/II Study of Umecrine Mood’s Candidate Drug for Premenstrual Dysphoric Disorder
More...
|
Promedior Presents Encouraging Results From Clinical Study of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis
More...
|
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease
More...
|
Arsanis, Inc. Nominates Preclinical Candidate for Staphylococcus aureus Program
More...
|
Pamlab LLC: New Research Highlights Biological and Genetic Markers Associated With Improved Response to Adjunctive L-Methylfolate in Management of Depression
More...
|
Elan Corporation PLC (ELN)’s Board of Directors Unanimously Reject Royalty Pharma’s Revised Tender Offer
More...
|
miRagen Therapeutics Achieves First Milestone in Strategic Alliance With Servier
More...
|
AIBioTech Receives Subcontract Award From DynPort Vaccine Company LLC, for Continued Development and FDA Approval of a Nerve Agent Prophylactic
More...
|
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene, Inc. Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
More...
|
Cenix BioScience GmbH and Debiopharm Collaborate to Identify Predictive Biomarkers
More...
|
College of Pharmacy Partners With TNI BioTech to Develop New Drugs for Africa
More...
|
Flamel Technologies (FLML) Obtains Rights to Two Molecules of Trigger Lock Product Line
More...
|
Indiana University and Regenstrief Receive PCORI Award to Improve Health Care Access for Underinsured
More...
|
AxoGen, Inc. (LECT) Receives Grant in Partnership With Vanderbilt University From U.S. Department of Defense
More...
|
MEDA: Dymista Reimbursed in Sweden
More...
|
Portola Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
More...
|
Apricus Biosciences (APRI) Prices $17.1 Million Public Offering of Common Stock and Warrants
More...
|
Stemline Therapeutics, Inc. (STML) Announces Exercise of Option to Purchase Additional Shares
More...
|
Zealand Pharma - Announcement of Transactions in the Company’s Shares and Related Securities by Executives and Their Related Parties
More...
|
Advaxis, Inc. Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
More...
|
Apricus Biosciences (APRI) Announces Proposed Public Offering of Common Stock and Warrants
More...
|
BioTime (BTX) Announces Results of Vote at Special Meeting of Shareholders
More...
|
DiaGenic ASA: Annual General Meeting Held
More...
|
Aptiv Solutions Release: Tufts Center for the Study of Drug Development Study Finds Adoption of Adaptive Clinical Trial Designs Is Increasing
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Announces Improved Business Standards and Quality Assurance Initiatives
More...
|
AB SCIEX Improves Food Safety With New Method to Identify Markers for Horse Meat and the Banned Veterinary Drug Residue Phenylbutazone
More...
|
Alkermes plc (ALKS) Reports Financial Results for Fiscal Year 2013 and Provides Financial Expectations
More...
|
Pressure BioSciences, Inc. (BBII) to Discuss First Quarter 2013 Financial Results and Provide Business Update
More...
|
Phytopharm PLC (PYM.L) Interim Results for the Six Months Ended 31 March 2013
More...
|
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend
More...
|
Advanced Cell Technology Appoints Edward Myles as Chief Financial Officer
More...
|
Halozyme Therapeutics, Inc. (HALO) Names David A. Ramsay Chief Financial Officer
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
More...
|
Antares Pharma, Inc. (AIS) Welcomes Marvin Samson to Board of Directors
More...
|
BrainStorm Cell Therapeutics Inc. Announces CEO Interview With The Wall Street Analyst
More...
|
Cardinal Health, Inc. (CAH) Receives Platinum Best Employers for Healthy Lifestyles® Award
More...
|
Amyris, Inc. to Participate at the Cowen Technology, Media & Telecommunications Conference
More...
|
Galena Biopharma (GALE) to Present at the 2013 Marcum MicroCap Conference
More...
|
Dyax Corp. (DYAX) Announces Participation in Upcoming Investor Events
More...
|
Lightlake Therapeutics Inc. (LLTP)’ Binge Eating Disorder Treatment Phase II Trial Results Presented at American Psychiatric Association 2013 Annual Meeting
More...
|
Baxter International, Inc. (BAX) to Present at the Goldman, Sachs & Co. 34th Annual Global Healthcare Conference
More...
|
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders -- New Phone Number for Audio Portion of Presentation
More...
|
Organogenesis Inc. Presents Findings from Groundbreaking Research Highlighting the Healthcare Resource and Economic Burden of Venous Leg Ulcers and Diabetic Foot Ulcers
More...
|
Ligand Pharmaceuticals Inc. (LGND) to Present at Upcoming Investor Conferences
More...
|
DiaGenic ASA: Annual General Meeting Held
More...
|
Inhibikase Therapeutics to Present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)
More...
|
BioLife Solutions, Inc. (BLFS.OB) Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
More...
|
Verenium Corporation (VRNM) to Present at Two Upcoming Conferences
More...
|
Prometheus Laboratories Inc. Presents New Data On Growing IBD Diagnostic Portfolio at Digestive Disease Week 2013
More...
|
Amgen (AMGN) Announces Voting Results of Annual Meeting of Stockholders
More...
|
Heska Corporation (HSKA) to Present at the Stifel Dental & Veterinary Conference
More...
|
PAREXEL International (PRXL) to Present at Jefferies and Co. Healthcare Conference
More...
|
Cambrex Corporation (CBM) to Present at Jefferies and Co. 2013 Global Healthcare Conference
More...
|
Synageva BioPharma (GEVA) to Present at the Jefferies and Co. 2013 Global Healthcare Conference
More...
|
Konan Medical USA Inc. Release: Six Month Data Reported for WAVE I Study of Renal Denervation Therapy for Hypertension at EuroPCR Meeting in Paris
More...
|
Pharmagen to Present at the Second Annual Marcum LLP MicroCap Conference
More...
|
Targeted Medical Pharma to Present at Marcum MicroCap Conference
More...
|
CEL-SCI (CVM) to Present at the Second Annual Marcum LLP MicroCap Conference
More...
|
Cancer Genetics, Inc. to Present at Marcum MicroCap Conference
More...
|
Northwest Biotherapeutics (NWBT) Exhibit at the Upcoming American Society of Clinical Oncology Meeting to Highlight its Leadership Role in Immune Therapy for Cancer
More...
|
AEterna Zentaris (AEZS): Posters to be Presented on Phase 1 and Phase 2 Trials with AEZS-108 in Prostate and Breast Cancer at Upcoming American Society of Clinical Oncology Meeting
More...
|
Verastem, Inc. (VSTM) to Present at the 2013 American Society of Clinical Oncology Annual Meeting
More...
|
Biogen Idec, Inc. (Massachusetts) (BIIB) to Present at the Deutsche Bank (DB) 38th Annual dbAccess Healthcare Conference
More...
|
NPS Pharmaceuticals, Inc. (NPSP) to Present at Deutsche Bank (DB) Health Care Conference
More...
|
Covidien (COV) and Mallinckrodt Inc. to Present at Deutsche Bank (DB) Conference
More...
|
Intercept Pharmaceuticals to Present at Deutsche Bank (DB) Healthcare Conference
More...
|
Isis Pharmaceuticals, Inc. (ISIS) to Present at the Deutsche Bank (DB) 38th Annual dbAccess Health Care Conference
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) to Present Corporate Update at the Deutsche Bank (DB) 38th Annual Health Care Conference in Boston on May 30th
More...
|
Ariad Pharmaceuticals, Inc. (ARIA) to Present at the Deutsche Bank (DB) 38th Annual Healthcare Conference
More...
|
Tesaro, Inc. to Present at the Deutsche Bank (DB) 38th Annual 2013 Health Care Conference
More...
|